Cargando…

A Randomized, Open Label, Exploratory Trial Comparing Efficacy of Amantadine and Ropinirole in Restless Legs Syndrome

Objective Amantadine has both anti-glutamatergic and dopaminergic action and may improve restless legs syndrome (RLS). We compared the efficacy and adverse-effect profile of amantadine and ropinirole in RLS. Methods In this randomized, open-label, 12-week flexible-dose exploratory study, RLS patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Madhaw, Govind, Gupta, Ravi, Dhamija, Puneet, Kumar, Niraj
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Thieme Revinter Publicações Ltda. 2023
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10325843/ https://www.ncbi.nlm.nih.gov/pubmed/37425973 http://dx.doi.org/10.1055/s-0043-1770810

Ejemplares similares

Ropinirole for the treatment of restless legs syndrome
por: Kushida, Clete A
Publicado: (2006)

Bupropion and Iron for Restless Leg Syndrome: Do They Have Efficacy Similar to Ropinirole?
por: Praharaj, Samir Kumar
Publicado: (2017)

Ropinirole in restless legs syndrome and periodic limb movement disorder
por: Erichsen, Daniel, et al.
Publicado: (2010)

A double-blind, randomized, controlled trial to compare the efficacy and tolerability of fixed doses of ropinirole, bupropion, and iron in treatment of restless legs syndrome (Willis–Ekbom disease)
por: Vishwakarma, Kirti, et al.
Publicado: (2016)

The Effect of Ropinirole on the Quality of Life in Patients with Restless Legs Syndrome in Korea: An 8-Week, Multicenter, Prospective Study
por: Cho, Yong Won, et al.
Publicado: (2013)

Modification and Validation of a Diagnostic Questionnaire for Restless Legs Syndrome: Modified-Restless Legs Syndrome Diagnostic Questionnaire (m-RLS-DQ)
por: Kumar, Rohit, et al.
Publicado: (2023)

Restlessness in right upper limb as sole presentation of restless legs syndrome
por: Gupta, Ravi, et al.
Publicado: (2013)

Primary headaches in restless legs syndrome patients
por: Gupta, Ravi, et al.
Publicado: (2012)

MON-282 Treatment of Hyperprolactinemia with Ropinirole: An Open-Label Dose Escalation Study
por: Tsang, Amanda, et al.
Publicado: (2020)

Restless Legs Syndrome and Leg Motor Restlessness in Parkinson's Disease
por: Suzuki, Keisuke, et al.
Publicado: (2015)

Prevalence of restless leg syndrome in subjects with depressive disorder
por: Gupta, Ravi, et al.
Publicado: (2013)

Dietary and Environmental Risk Factors in Parkinson’s Disease and Alzheimer’s Disease: Beware of Your Food Plate and Your Surroundings!
por: Madhaw, Govind, et al.
Publicado: (2023)

Comparative Efficacy and Safety of Clonazepam versus Nortriptyline in Restless Leg Syndrome among Forty Plus Women: A Prospective, Open-Label Randomized Study
por: Roshi,, et al.
Publicado: (2019)

Gabapentin enacarbil – clinical efficacy in restless legs syndrome
por: Agarwal, Pinky, et al.
Publicado: (2010)

Restless Leg Syndrome in Diabetics Compared with Normal Controls
por: Zobeiri, Mehdi, et al.
Publicado: (2014)

External Anal- and Urethral-Sphincter Electromyography for Differentiating MSA-P, PD and PSP: Using a Needle to Sort the Haystack!
por: Dhar, Nikita, et al.
Publicado: (2023)

Diabetic Painful Neuropathy and Restless Legs Syndrome in Diabetes
por: Kalra, Sanjay, et al.
Publicado: (2018)

Restless Chest Syndrome: A Rare Variant of Restless Legs Syndrome
por: Ishizuka, Kosuke, et al.
Publicado: (2022)

A Prospective, Randomized, Open-Label Study Comparing the Efficacy and Safety of Clonazepam versus Nortriptyline on Quality of Life in 40+ Years old Women Presenting with Restless Leg Syndrome
por: Roshi,, et al.
Publicado: (2018)

Impulse-Control Disorders and Restless Legs Syndrome in Parkinson’s Disease: Are they Close Together or Far Apart?
por: Desai, Ishita, et al.
Publicado: (2023)

Migraine and restless legs syndrome: is there an association?
por: Cannon, Paul R., et al.
Publicado: (2011)

Restless Legs Syndrome: The underrecognised condition
por: Benamer, Hani
Publicado: (2006)

Migraine with aura and restless legs syndrome
por: Larner, Andrew J.
Publicado: (2007)

The Neurobiology and Treatment of Restless Legs Syndrome
por: Jones, Ruth, et al.
Publicado: (2013)

Peripheral Dopamine in Restless Legs Syndrome
por: Mitchell, Ulrike H., et al.
Publicado: (2018)

Unraveling the Mysteries of Restless Leg Syndrome
por: Memon, Mohammad D, et al.
Publicado: (2020)

Restless legs syndrome: causes and consequences
por: Massey, T. H., et al.
Publicado: (2020)

Pharmacologic Treatment of Restless Legs Syndrome
por: Lv, Qing, et al.
Publicado: (2021)

Circadian rhythm in restless legs syndrome
por: Tang, Mingyang, et al.
Publicado: (2023)

Restless Legs Syndrome in Parkinson’s Disease
por: Diaconu, Ştefania, et al.
Publicado: (2023)

Tenecteplase and Alteplase for Thrombolysis of Acute Ischemic Stroke within 4.5 Hours: An Efficacy and Safety Study
por: Dhar, Nikita, et al.
Publicado: (2022)

The Safety and Efficacy of Pregabalin Add-on Therapy in Restless Legs Syndrome Patients
por: Bae, Hyoeun, et al.
Publicado: (2021)

Restless abdomen: a spectrum or a phenotype variant of restless legs syndrome?
por: Wang, Xi-Xi, et al.
Publicado: (2020)

Translation and validation of International Restless Leg Syndrome Study Group rating scale in Hindi language
por: Gupta, Ravi, et al.
Publicado: (2011)

Cost-Effectiveness of Tonic Motor Activation (TOMAC) Therapy for Patients with Restless Legs Syndrome: An Exploratory Analysis
por: Ryschon, Anne M., et al.
Publicado: (2023)

Update on ropinirole in the treatment of Parkinson’s disease
por: Shill, Holly A, et al.
Publicado: (2009)

Spectrophotometric Estimation of Ropinirole Hydrochloride in Tablets
por: Shete, Yogita, et al.
Publicado: (2009)

Treatment of Gait Ignition Failure with Ropinirole
por: Cohen-Oram, Alexis N., et al.
Publicado: (2014)

Long-term efficacy and safety of tonic motor activation for treatment of medication-refractory restless legs syndrome: A 24-Week Open-Label Extension Study
por: Roy, Asim, et al.
Publicado: (2023)

Amantadine and the Risk of Dyskinesia in Patients with Early Parkinson’s Disease: An Open-Label, Pragmatic Trial
por: Kim, Aryun, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_pfdf8h4pmf3mboi97sukrtla24